ponatinib
incyte,otsuka,takeda
['ph+ all', 'ponatinib', 'cml', 'leusm']
#asco22 #leusm leonard: blin + tki poised to revolutionize the treatment of ph+ all. presented blin + ponatinib with 85% cmr in front-line. fewer deep responded in cml-bc. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)